Evidence map›Paper›PMID 26827712›Full record

ReviewMatrix biology : journal of the International Society for Matrix Biology2016

Keloids: Animal models and pathologic equivalents to study tissue fibrosis.

Jaana Marttala, Jonathan P Andrews, Joel Rosenbloom, Jouni Uitto

Open access · greenAbstract readReview
In one paragraph

Review in Matrix biology : journal of the International Society for Matrix Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Downregulated cytotoxic CD8Cellular & molecular immunology · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Keloids: a review of therapeutic management.International journal of dermatology · 2021
    Review
  18. Emerging and Novel Therapies for Keloids: A compendious review.Sultan Qaboos University medical journal · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jaana MarttalaDepartment of Dermatology and Cutaneous Biology, The Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA.
Jonathan P AndrewsDepartment of Dermatology and Cutaneous Biology, The Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA.
Joel RosenbloomDepartment of Dermatology and Cutaneous Biology, The Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA; The Joan and Joel Rosenbloom Research Center for Fibrotic Diseases, Thomas Jefferson University, Philadelphia, PA 19107, USA; Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Jouni UittoDepartment of Dermatology and Cutaneous Biology, The Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA; Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. Electronic address: jouni.uitto@jefferson.edu.
Thomas Jefferson University · USJefferson Institute · US

Funding

TRAINING IN MOLECULAR DERMATOLOGY AND CUTANEOUS CONNECTIVE TISSUE DISEASEST32AR060715 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI UITTO, JOUNI · 2011 to 2015
$728k
NIAMS NIH HHS T32 AR060715
6 · The paper itself

Abstract

Animal models are crucial for the study of fibrosis. Keloids represent a unique type of fibrotic scarring that occurs only in humans, thus presenting a challenge for those studying the pathogenesis of this disease and its therapeutic options. Here, several animal models of fibrosis currently in use are described, emphasizing recent progress and highlighting encouraging challenges.

Indexed as

AnimalsCicatrix, HypertrophicDisease Models, AnimalFibroblastsFibrosisHumansKeloidMiceProtein Serine-Threonine KinasesProtein Serine-Threonine KinasesTsk1 protein, mouseAnimal modelsHypertrophic scarKeloidsTissue fibrosis

Identifiers

PMID26827712
PMCPMC4842112
OpenAlexW2306003449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.